Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications can cause serious side effects, so it's important to report them.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

The document doesn't provide enough information to summarize.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Baricitinib works better than methotrexate for severe alopecia areata.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

New treatments aim to improve thin endometrium to help more couples with infertility.

Replenishing iron after phlebotomy can cause relapse in porphyria cutanea tarda.

Rivaroxaban may cause hair loss.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

Propylthiouracil treatment can cause hair loss.

Dutasteride for hair loss might increase the risk of a rare stroke type.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Platelet-rich plasma therapy is seen as a promising tissue repair method but lacks standardized protocols.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Oral dexamethasone may help regrow hair in adults with alopecia totalis and universalis.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Tofacitinib may help treat hair loss in children with alopecia areata.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.